Published in Arch Intern Med on May 09, 2011
The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers. Rejuvenation Res (2014) 2.02
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Medication adherence: a call for action. Am Heart J (2011) 1.85
Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation (2013) 1.68
A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med (2011) 1.33
How do we improve patient compliance and adherence to long-term statin therapy? Curr Atheroscler Rep (2013) 1.20
Surveillance of medication use: early identification of poor adherence. J Am Med Inform Assoc (2011) 1.13
The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med (2011) 1.08
Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient (2013) 0.94
Medication adherence to multidrug regimens. Clin Geriatr Med (2012) 0.94
Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. J Gen Intern Med (2016) 0.94
Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence (2013) 0.94
Adherence to chronic disease medications among New York City Medicaid participants. J Urban Health (2013) 0.92
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr (2015) 0.91
Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence (2012) 0.89
Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients. Med Care (2012) 0.87
Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D. J Am Geriatr Soc (2014) 0.85
When comorbidity, aging, and complexity of primary care meet: development and validation of the Geriatric CompleXity of Care Index. J Am Geriatr Soc (2013) 0.85
Development and validation of the Hypertension Self-care Profile: a practical tool to measure hypertension self-care. J Cardiovasc Nurs (2014) 0.85
Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques. Health Serv Res (2015) 0.85
Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications? PLoS One (2015) 0.84
Patient complexity and risk factor control among multimorbid patients with type 2 diabetes: results from the R2D2C2 study. Med Care (2013) 0.83
Prescription refill management and its effect on adherence: comment on "the implications of therapeutic complexity on adherence to cardiovascular medications". Arch Intern Med (2011) 0.82
Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study. Medicine (Baltimore) (2015) 0.82
A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods. J Racial Ethn Health Disparities (2016) 0.81
Scalable decision support at the point of care: a substitutable electronic health record app for monitoring medication adherence. Interact J Med Res (2013) 0.81
Reconsideration of key articles regarding medication-related problems in older adults from 2011. Am J Geriatr Pharmacother (2012) 0.81
ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes. Ethn Dis (2013) 0.79
Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res (2012) 0.79
Helping our patients to adhere to chronic medications: a new arrow for the quiver. J Gen Intern Med (2011) 0.79
Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care. Eur J Clin Pharmacol (2012) 0.79
Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control. J Clin Hypertens (Greenwich) (2015) 0.78
Cumulative changes in the use of long-term medications: a measure of prescribing complexity. JAMA Intern Med (2013) 0.78
Using machine learning to examine medication adherence thresholds and risk of hospitalization. Med Care (2015) 0.78
Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation. Ann Am Thorac Soc (2015) 0.78
Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health, Aging and Body Composition Study. J Pharm Technol (2012) 0.77
Prevalent but moderate variation across small geographic regions in patient nonadherence to evidence-based preventive therapies in older adults after acute myocardial infarction. Med Care (2014) 0.77
Place matters: the problems and possibilities of spatial data in electronic health records. AMIA Annu Symp Proc (2013) 0.76
Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE). Health Serv Res (2014) 0.75
Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications. Clin Appl Thromb Hemost (2016) 0.75
Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014. PLoS One (2016) 0.75
Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data. BMJ Open (2016) 0.75
Patient-Centred Care of Older Adults With Cardiovascular Disease and Multiple Chronic Conditions. Can J Cardiol (2016) 0.75
Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus. Pharmacotherapy (2016) 0.75
Influence of therapeutic complexity on medication adherence in the Netherlands. Arch Intern Med (2011) 0.75
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review. Syst Rev (2012) 0.75
Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice. Cardiol Ther (2017) 0.75
MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol. BMJ Open (2017) 0.75
A simple informative intervention in primary care increases statin adherence. Eur J Clin Pharmacol (2015) 0.75
Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries. AIDS (2017) 0.75
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Risk factors for retained instruments and sponges after surgery. N Engl J Med (2003) 8.93
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med (2006) 7.08
Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med (2006) 6.70
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA (2005) 5.96
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Physician-citizens--public roles and professional obligations. JAMA (2004) 4.68
Analysis of errors reported by surgeons at three teaching hospitals. Surgery (2003) 4.66
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
New FDA breakthrough-drug category--implications for patients. N Engl J Med (2014) 4.30
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
The reliability of medical record review for estimating adverse event rates. Ann Intern Med (2002) 4.02
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
The rise of litigation in human subjects research. Ann Intern Med (2003) 3.77
Obesity and migraine: a population study. Neurology (2005) 3.67
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
The new medical malpractice crisis. N Engl J Med (2003) 3.41
Medical malpractice. N Engl J Med (2004) 3.38
Obesity--the new frontier of public health law. N Engl J Med (2006) 3.36
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
Rethinking the use of physicians as hired expert lecturers. Ann Intern Med (2014) 3.22
Direct-to-consumer marketing of high-technology screening tests. N Engl J Med (2002) 3.17
Drug-review deadlines and safety problems. N Engl J Med (2008) 3.16
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med (2009) 3.08
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA (2005) 2.95
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
Internet marketing of herbal products. JAMA (2003) 2.77
Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA (2004) 2.77
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
A middle ground on public accountability. N Engl J Med (2004) 2.72
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Sending pharma better signals. Science (2005) 2.69
Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med (2006) 2.67
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. JAMA (2011) 2.60
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. Arch Dermatol (2006) 2.56
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55
Patients' perceptions of generic medications. Health Aff (Millwood) (2009) 2.54
Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med (2015) 2.53